Intervention not reported
eGFR: final or change (mL/min) · adults and children with CKD
1 finding from 1 review
Cardiovascular mortality · people with CKD
It is very uncertain whether patient‐centred outcomes for oral changes cardiovascular death compared with IV iron (very low certainty).
1 finding from 1 review
Type of adverse event: allergic reactions/hypotension · people with CKD
Patient‐centred outcomes for oral may leads to higher type of adverse event: allergic reactions/hypotension compared with IV iron (low certainty).
1 finding from 1 review
Gastrointestinal effects · people with CKD
Patient‐centred outcomes for oral may leads to lower type of adverse event: all gastrointestinal adverse effects compared with IV iron (low certainty).
1 finding from 1 review
Type of adverse event: infection · people with CKD
Patient‐centred outcomes for oral showed no clear difference in type of adverse event: infection compared with IV iron (low certainty).
1 finding from 1 review
Numbers of non‐dialysis patients needing to commence dialysis · people with CKD
Patient‐centred outcomes for oral showed no clear difference in numbers of non‐dialysis patients needing to commence dialysis compared with IV iron (low certainty).
1 finding from 1 review
Blood transfusion · people with CKD
Patient‐centred outcomes for oral showed no clear difference in number requiring transfusion compared with IV iron (low certainty).
1 finding from 1 review
Intervention not reported
Number achieving target Hb or increase ≥1 g/dL · adults and children with CKD
The intervention may leads to higher number achieving target Hb or increase ≥1 g/dL (low certainty).
1 finding from 1 review
Intervention not reported
Hb: final or change (g/dL) · adults and children with CKD
1 finding from 1 review
Incidence of NEC within 48 hours after transfusion · preterm infants receiving transfusion
1 finding from 1 review
Incidence of NEC any time after first transfusion · preterm infants receiving transfusion
1 finding from 1 review
Mortality to 44 weeks' postmenstrual age · preterm infants receiving transfusion
1 finding from 1 review
Length of hospital stay · preterm infants receiving transfusion
1 finding from 1 review
Time (days) to achieve exclusive oral feeding · preterm infants receiving transfusion
1 finding from 1 review
Feed intolerance · preterm infants receiving transfusion
1 finding from 1 review
Growth · preterm infants receiving transfusion
1 finding from 1 review
Mortality before hospital discharge · preterm infants
Higher showed no clear difference in mortality to hospital discharge compared with lower amino acid intake (low certainty).
1 finding from 1 review
Neurodevelopmental disability · preterm infants
It is very uncertain whether higher changes neurodevelopmental disability compared with lower amino acid intake (very low certainty).
1 finding from 1 review
Postnatal growth failure (weight < 10th percentile) · preterm infants
It is very uncertain whether higher changes postnatal growth failure at discharge (weight < 10th centile) compared with lower amino acid intake (very low certainty).
1 finding from 1 review
Weight gain · preterm infants
1 finding from 1 review